glp-1 agonists vs bariatric surgery weight loss comparison Metabolic and versus glucagon-like peptide-1 receptor agonist therapy: A of cardiovascular outcomes in patients with obesity Ozempic or Bariatric Surgery: Which
Description
Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, et al
10.1186/s12902-024-01775-2 69 SommE.MontandonS
This may help with faster or greater weight loss compared to semaglutide for some individuals
aimed to compare the effects of retatrutide, liraglutide, and tirzepatide on diabetic kidney disease in db/db mice [41]
K., Dai, W., Zheng, Y
The capacity of GLP-1 RAs to decelerate gastric emptying to levels indicative of gastroparesis raises concerns regarding potential intestinal obstruction and perioperative aspiration risk
